The Joint Corp. (NASDAQ:JYNT - Free Report) - Analysts at Roth Capital reduced their Q3 2024 earnings per share estimates for Joint in a report released on Thursday, May 2nd. Roth Capital analyst G. Kelly now anticipates that the company will post earnings of $0.09 per share for the quarter, down from their prior estimate of $0.10. The consensus estimate for Joint's current full-year earnings is $0.13 per share. Roth Capital also issued estimates for Joint's Q4 2024 earnings at $0.16 EPS, Q1 2025 earnings at $0.11 EPS, Q2 2025 earnings at $0.17 EPS and Q4 2025 earnings at $0.24 EPS.
Joint (NASDAQ:JYNT - Get Free Report) last announced its quarterly earnings data on Thursday, March 7th. The company reported $0.07 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.03 by $0.04. The firm had revenue of $30.61 million during the quarter, compared to analyst estimates of $29.63 million. Joint had a negative net margin of 9.24% and a positive return on equity of 3.94%.
A number of other research analysts have also recently commented on JYNT. Roth Mkm reaffirmed a "buy" rating and issued a $16.00 target price (up previously from $13.00) on shares of Joint in a research report on Friday. TheStreet cut shares of Joint from a "c-" rating to a "d" rating in a research report on Thursday, March 7th. Finally, B. Riley boosted their target price on Joint from $12.00 to $20.00 and gave the company a "buy" rating in a research report on Monday. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $22.00.
View Our Latest Stock Analysis on Joint
Joint Stock Performance
Shares of Joint stock traded down $0.33 during trading hours on Monday, hitting $15.79. The company's stock had a trading volume of 143,009 shares, compared to its average volume of 90,058. The firm has a fifty day moving average of $12.17 and a 200-day moving average of $10.21. The stock has a market cap of $235.90 million, a price-to-earnings ratio of -21.05 and a beta of 1.58. Joint has a twelve month low of $7.31 and a twelve month high of $16.35.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently bought and sold shares of the stock. First Foundation Advisors acquired a new stake in Joint in the 3rd quarter valued at about $1,336,000. Skylands Capital LLC raised its holdings in Joint by 20.3% in the fourth quarter. Skylands Capital LLC now owns 603,640 shares of the company's stock valued at $5,801,000 after acquiring an additional 101,850 shares in the last quarter. Hudson Bay Capital Management LP purchased a new position in Joint in the third quarter worth approximately $867,000. Russell Investments Group Ltd. acquired a new position in Joint during the 4th quarter worth approximately $795,000. Finally, Sierra Summit Advisors LLC acquired a new position in Joint during the 4th quarter worth approximately $652,000. 76.88% of the stock is currently owned by hedge funds and other institutional investors.
About Joint
(
Get Free Report)
The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Featured Stories
Before you consider Joint, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Joint wasn't on the list.
While Joint currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
